An Adaptive Seamless Randomized, Double-blind, Placebo-controlled, Dose Ranging Study to Investigate the Efficacy and Safety of LNP023 in Primary IgA Nephropathy Patients
收藏DataCite Commons2026-03-27 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00012937/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
Efficacy and safety of LNP023 in IgAN patients
提供机构：
Vivli
创建时间：
2026-03-27
